OSLO, Norway--(BUSINESS WIRE)--Regulatory News:
First mover in blood based CNS biomarkers
The interim report for the fourth quarter 2011 was approved by the Board of Directors on 13 February 2011. Please find the interim report and presentation attached. Highlights from the report:
MCItect®: The first blood based test for early Alzheimer disease (AD)
